Copyright Reports & Markets. All rights reserved.

Global GMP Plasmid DNA Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global GMP Plasmid DNA Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Standard
      • 1.4.3 Ultra-Pure
    • 1.5 Market by Application
      • 1.5.1 Global GMP Plasmid DNA Market Share by Application (2014-2025)
      • 1.5.2 DNA Vaccines
      • 1.5.3 Gene Therapy
      • 1.5.4 Immunotherapy
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 GMP Plasmid DNA Market Size
    • 2.2 GMP Plasmid DNA Growth Trends by Regions
      • 2.2.1 GMP Plasmid DNA Market Size by Regions (2014-2025)
      • 2.2.2 GMP Plasmid DNA Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 GMP Plasmid DNA Market Size by by Players
      • 3.1.1 Global GMP Plasmid DNA Revenue by by Players (2014-2019)
      • 3.1.2 Global GMP Plasmid DNA Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global GMP Plasmid DNA Market Concentration Ratio (CR5 and HHI)
    • 3.2 GMP Plasmid DNA Key Players Head office and Area Served
    • 3.3 Key Players GMP Plasmid DNA Product/Solution/Service
    • 3.4 Date of Enter into GMP Plasmid DNA Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global GMP Plasmid DNA Market Size by Type (2014-2019)
    • 4.2 Global GMP Plasmid DNA Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States GMP Plasmid DNA Market Size (2014-2019)
    • 5.2 GMP Plasmid DNA Key Players in United States
    • 5.3 United States GMP Plasmid DNA Market Size by Type
    • 5.4 United States GMP Plasmid DNA Market Size by Application

    6 Europe

    • 6.1 Europe GMP Plasmid DNA Market Size (2014-2019)
    • 6.2 GMP Plasmid DNA Key Players in Europe
    • 6.3 Europe GMP Plasmid DNA Market Size by Type
    • 6.4 Europe GMP Plasmid DNA Market Size by Application

    7 China

    • 7.1 China GMP Plasmid DNA Market Size (2014-2019)
    • 7.2 GMP Plasmid DNA Key Players in China
    • 7.3 China GMP Plasmid DNA Market Size by Type
    • 7.4 China GMP Plasmid DNA Market Size by Application

    8 Japan

    • 8.1 Japan GMP Plasmid DNA Market Size (2014-2019)
    • 8.2 GMP Plasmid DNA Key Players in Japan
    • 8.3 Japan GMP Plasmid DNA Market Size by Type
    • 8.4 Japan GMP Plasmid DNA Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia GMP Plasmid DNA Market Size (2014-2019)
    • 9.2 GMP Plasmid DNA Key Players in Southeast Asia
    • 9.3 Southeast Asia GMP Plasmid DNA Market Size by Type
    • 9.4 Southeast Asia GMP Plasmid DNA Market Size by Application

    10 India

    • 10.1 India GMP Plasmid DNA Market Size (2014-2019)
    • 10.2 GMP Plasmid DNA Key Players in India
    • 10.3 India GMP Plasmid DNA Market Size by Type
    • 10.4 India GMP Plasmid DNA Market Size by Application

    11 Central & South America

    • 11.1 Central & South America GMP Plasmid DNA Market Size (2014-2019)
    • 11.2 GMP Plasmid DNA Key Players in Central & South America
    • 11.3 Central & South America GMP Plasmid DNA Market Size by Type
    • 11.4 Central & South America GMP Plasmid DNA Market Size by Application

    12 International Players Profiles

    • 12.1 Cobra Bio
      • 12.1.1 Cobra Bio Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 GMP Plasmid DNA Introduction
      • 12.1.4 Cobra Bio Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.1.5 Cobra Bio Recent Development
    • 12.2 Waisman Biomanufacturing
      • 12.2.1 Waisman Biomanufacturing Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 GMP Plasmid DNA Introduction
      • 12.2.4 Waisman Biomanufacturing Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.2.5 Waisman Biomanufacturing Recent Development
    • 12.3 Gedeon Richter
      • 12.3.1 Gedeon Richter Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 GMP Plasmid DNA Introduction
      • 12.3.4 Gedeon Richter Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.3.5 Gedeon Richter Recent Development
    • 12.4 Eurogentec
      • 12.4.1 Eurogentec Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 GMP Plasmid DNA Introduction
      • 12.4.4 Eurogentec Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.4.5 Eurogentec Recent Development
    • 12.5 VGXI
      • 12.5.1 VGXI Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 GMP Plasmid DNA Introduction
      • 12.5.4 VGXI Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.5.5 VGXI Recent Development
    • 12.6 PlasmidFactory
      • 12.6.1 PlasmidFactory Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 GMP Plasmid DNA Introduction
      • 12.6.4 PlasmidFactory Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.6.5 PlasmidFactory Recent Development
    • 12.7 Kaneka
      • 12.7.1 Kaneka Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 GMP Plasmid DNA Introduction
      • 12.7.4 Kaneka Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.7.5 Kaneka Recent Development
    • 12.8 Delphi Genetics
      • 12.8.1 Delphi Genetics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 GMP Plasmid DNA Introduction
      • 12.8.4 Delphi Genetics Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.8.5 Delphi Genetics Recent Development
    • 12.9 Nature Technology Corporation
      • 12.9.1 Nature Technology Corporation Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 GMP Plasmid DNA Introduction
      • 12.9.4 Nature Technology Corporation Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.9.5 Nature Technology Corporation Recent Development
    • 12.10 LakePharma
      • 12.10.1 LakePharma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 GMP Plasmid DNA Introduction
      • 12.10.4 LakePharma Revenue in GMP Plasmid DNA Business (2014-2019)
      • 12.10.5 LakePharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      GMP plasmid DNA, or GMP Grade Plasmid DNA can be used for direct injection as DNA vaccines, gene therapy, or ex-vivo applications such as cell and gene therapies. Compare with other Plasmid DNA, GMP Plasmid has no animal derived enzymes or organic solvents.
      In 2018, the global GMP Plasmid DNA market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global GMP Plasmid DNA status, future forecast, growth opportunity, key market and key players. The study objectives are to present the GMP Plasmid DNA development in United States, Europe and China.

      The key players covered in this study
      Cobra Bio
      Waisman Biomanufacturing
      Gedeon Richter
      Eurogentec
      VGXI
      PlasmidFactory
      Kaneka
      Delphi Genetics
      Nature Technology Corporation
      LakePharma

      Market segment by Type, the product can be split into
      Standard
      Ultra-Pure

      Market segment by Application, split into
      DNA Vaccines
      Gene Therapy
      Immunotherapy
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global GMP Plasmid DNA status, future forecast, growth opportunity, key market and key players.
      To present the GMP Plasmid DNA development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of GMP Plasmid DNA are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now